I followed this stock in 2005 on the move from $1 to $8. That move was entirely based on the Evian Bird Flu epidemic. The Govt. stated they were ready to purchase 250 million vaccinations for the U.S. if needed. The deal never panned out - NVAX went back to the drawing board. They have yet to close any product sales.
It's sad to think the fate of this company rested on a Bird Flu outbreak then.